Report for Q3 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(688520)"Sinocelltech Group Limited"Report for Q3 2026
Filed with SSE · Stock code 688520 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Sinocelltech Group Limited on 6ix
Earlier from Sinocelltech
- (688520)"Sinocelltech Group Limited"Announcement on Shareholding Reduction Plan of Shareholders
- (688520)"Sinocelltech Group Limited"Announcement on Voluntary Disclosure of Receipt of the Clinical Trial Approval Notice for the Controlled Subsidiary's Product SCT810
- Announcement on Shareholding Reduction Plan of Shareholder
- Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry
- Semi-annual Report for 2026
Later from Sinocelltech
All Sinocelltech news releasesFollow Sinocelltech into a list and get an email when it puts out news.
Follow Sinocelltech